The body first encounters deleterious inhaled substances, such as allergens, industrial particles, pollutants, and infectious agents, at the airway epithelium. When this occurs, the epithelium and its resident inflammatory cells respond defensively by increasing production of cytokines, mucus, and reactive oxygen and nitrogen species (ROS/RNS). As inflammation in the airway increases, additional infiltrating cells increase the level of these products. Recent interest has focused on ROS/RNS as potential modulators of the expression of inflammation-associated genes important to the pathogenesis of various respiratory diseases. ROS/RNS appear to play a variety of roles that lead to changes in expression of genes such as interleukin-6 and intercellular adhesion molecule 1. By controlling this regulation, the reactive species can serve as exogenous stimuli, as intercellular signaling molecules, and as modulators of the redox state in epithelial cells. Unraveling the molecular mechanisms affected by ROS/RNS acting in these capacities should aid in the understanding of how stimulated defense mechanisms within the airway can lead to disease.
Introduction
The airway epithelium is the body's first physiologic barrier to deleterious airborne substances such as allergens, industrial particles, pollutants, and infectious agents. As a first line of defense, these offending substances are sequestered in the mucus layer covering the airway, where ciliary movement can remove them (1, 2) . Resident phagocytic cells also function in this removal process (3) . Furthermore, as the epithelial cells encounter these inhaled substances, they respond defensively by producing inflammatory cytokines, increasing mucus secretion, and generating reactive oxygen and nitrogen species (ROS/RNS) (4) .
Substances produced by the epithelial cells after inhalation of deleterious substances can play a role in recruiting inflammatory cells to the airway. Interleukin (IL)-6, for example, secreted in response to pollutants, particles or allergens, recruits monocytes. Additional chemoattractive substances released by epithelial cells direct infiltration of B and T lymphocytes, neutrophils, basophils, and eosinophils (5) .
Infiltrating inflammatory cells, together with resident and infiltrating alveolar macrophages, mount specific defenses against inhaled deleterious substances. For example, antibody production against incoming allergens occurs as IL-6 promotes activation of infiltrating B and T lymphocytes (6) . Accumulating neutrophils and macrophages generate and release large amounts of ROS/RNS in a respiratory burst designed to combat inhaled infectious agents such as bacteria and viruses (7) . ROS/RNS, produced either during this respiratory burst or inhaled into the airway, elicit a variety of responses from airway epithelium. Exogenous ROS have been shown to cause an increase in mucin secretion (8) , as well as to stimulate enzymes such as phospholipase C that serve as important roles in signal transduction cascades within cells (9) . Inhaled oxidants such as ozone induce DNA-binding activity of transcription factors such as nuclear factor kappa B (NF-icB), nuclear factor IL-6 (NFIL-6), and activator protein 1 (AP-1) in type II-like epithelial cells (A549), demonstrating a potential role for epithelial cells in the oxidant-induced expression of cytokines such as IL-8 (10) .
The epithelium can also produce ROS/RNS directly. Bronchial and tracheal epithelial cells release H202 in response to inflammatory stimuli (11, 12) . Nitric oxide ('NO) can be produced in response to various cytokines or endotoxin by an inducible form of nitric oxide synthase (iNOS) localized to the airway epithelium (13) (14) (15) (16) . Together with released ROS/RNS, airway epithelial cells also produce intracellular ROS/RNS that serve as signaling molecules, provoking changes in mucin secretion and integrin expression (8, 9, 17, 18 (23) .
Therapies that increase oxygenation of the body's organ systems during congestive lung diseases such as cystic fibrosis, COPD, and ARDS are also a source of exogenous ROS/RNS (24) . Based on observed abnormal changes, this prolonged exposure to high oxygen concentrations combined with positive pressure mechanical ventilation can cause acute lung injury (25) (26) . Reactive species in affected airways result mainly from the respiratory burst of stimulated macrophages and from stimulated polymorphonuclear leukocytes (neutrophils) (7) .
Endogenous Sources of ROSIRNS. Endogenous reactive species can also be generated within the airway epithelial cells in response to proinflammatory cytokines such as tumor necrosis factor alpha (TNFa) (27, 28) . This relationship is evidenced by the conversion of cellular glutathione to its oxidized form, presumably as a protection against increased intracellular oxidants, following exposure of human epithelial type II cells (A549) to TNF-a (29) . At least some of the reactive species generated in response to TNF-a appear to be side products derived from electron transport reactions taking place in mitochondria of stimulated cells (28, 30) . TNF-a can also upregulate gene expression and activity of xanthine oxidase, a very abundant enzyme in epithelial cells, which can lead to generation of superoxide anion radical and H202 from oxygen encountered within airways. The presence of additional cytokines such as interferon-y, IL-1, and IL-6 causes additive effects on xanthine oxidase upregulation, adding further to the oxidant burden within epithelial cells (31, 32) . Additional ROS are also formed in airway epithelium through the action of cell-associated oxidative enzymes such as NADPH oxidase and cyclooxygenase (33) . *NO, a highly reactive nitrogen species, is generated in response to inflammatory cytokines by the iNOS localized to airway epithelium (14 (45) . The prevalence of these enzymes in airway epithelial cells likely plays a role in maintaining a healthy airway. Glutathione is particularly abundant in lung epithelial lining fluids at concentrations approximately 100-fold greater than those observed in plasma (46) . Greater concentrations of total glutathione are observed in bronchial and alveolar fluid from asthmatics compared to that in normal control subjects (47) . These findings, coupled with an observed reduction in GSHPx levels in asthmatic adults and children (48) For cellular function to be modulated, the cell must respond to these shifts in oxidation-reduction equilibria, or to production of new reactive signaling molecules, through modulation of regulatory proteins that have the potential to initiate gene transcription (33, 61) , as illustrated in Figure 1 . Two transcription factors regulated by the redox state of the cell are NF-KB and AP-1 (62). Nuclear translocation and subsequent binding to DNA of the NF-KB complex occurs in response to H202, hypochlorous acid, and multiple cytokines (63, 64) . Once in the nucleus, these dimers bind a consensus sequence found in the promoter region of many genes, including those coding for cytokines such as IL-6, IL-8, IL-1, and Macrophage 0 TNF-a\ TNF-a. Activation of NF-icB has been demonstrated in inflammatory cells from patients with airway diseases, suggesting an in vivo role for this complex in regulating expression of these cytokine genes (65) . The activation of AP-1 appears to oppose that of NF-KB. For example, TNF-a-induced activation ofAP-1 can be increased by exposure to antioxidants such as pyrrolidine dithiocarbamate (PDTC) (66) .
ROS appear to regulate NF-KB function via effects on I-KB, a family of inhibitory subunits regulated by phosphorylation that controls the activity and nuclear translocation of NF-iKB. Specifically, intracellular ROS appear to play a key role in regulating phosphorylation of I-KB. For example, cells overexpressing GSHPx exhibit decreased translocation of NF-icB and decreased phosphorylation of I-KB in response to oxidative stress or TNF-a exposure. A correlation also exists between the rise in ROS levels in TNF-ax-stimulated cells and the degradation of I-KB, which presumably occurs because of the increase in its (70, 71) . Preliminary studies from our laboratory suggest protein kinase C (PKC) translocation and activation is stimulated by ROS produced from purine + xanthine oxidase in GPTE and BEAS-2B cells.
Other enzymes associated with intracellular signaling pathways may also be redox sensitive. At least two members of the src family of protein tyrosine kinases have been activated by H202. In addition, the protein tyrosine kinase syk is responsive to treatment of B cells with H202 (72) . Protein-tyrosine phosphatases have reactive cysteine residues in their active sites that may make these enzymes oxidant sensitive (73) . Studies using inhibitors have also suggested that IL-8 gene expression in response to asbestos exposure may be governed by redoxinduced changes leading to phosphorylation events, mediated by tyrosine kinases. In addition, this signaling pathway may involve PKC. Ultimately, the phosphorylation events set in motion by this redox-sensitive pathway appear to activate nudear proteins that recognize the NF-cB/NFIL-6 sites of the IL-8 promoter, contributing to IL-8 gene expression (74) .
Other steps in intracellular signaling pathways may also be oxidant regulated. For example, hydroperoxides increase the concentration of intracellular calcium (75, 76) . Some studies suggest that H202 treatment induces inositol-1,4,5-triphosphate (IP3) production, which allows IP3 to bind to receptors on the endoplasmic reticulum and provoke release of intracellularly stored calcium (72) . It may be this increase in calcium that then stimulates phospholipase activity resulting in proteolytic events that have direct effects on the activation of transcription factors such as NF-icB (61, 76) .
Role of ROS/RNS in Inflammatory Respiratory Disease Expression ofInflammaionAssodated Genes
A number of genes and their products are upregulated in patients with respiratory diseases such as asthma, chronic bronchitis, COPD, cystic fibrosis, and ARDS. IL-6 levels are increased in bronchoalveolar lavage (BAL) fluid taken from asthmatics compared to levels in BAL from control subjects (26) . Epithelial cells from asthmatics also show a corresponding increase in IL-6 mRNA (77). IL-8 levels are increased in sputum from COPD patients compared with those in sputum of control subjects (nonsmokers, cigarette smokers without disease, or asthmatic patients) (78) . A similar increase in the expression of intercellular adhesion molecule 1 (ICAM-1) has been observed in asthma, chronic bronchitis, ARDS, and COPD (79, 80) . ICAM-1 promotes immunologic and inflammatory reactions such as leukocyte diapedesis within the lung. Because ICAM-1 appears to be important for the adhesion of inflammatory cells in the airway, its overexpression may allow more inflammatory cells to remain in the airway for long periods of time. This persistence of inflammatory cells in the airway likely plays a role in exacerbating the injury and inflammation observed in respiratory diseases. For example, the presence of neutrophils results in release of substantial amounts of ROS and destructive enzymes such as elastase (7) . In ARDS, such activated neutrophils also release cytokines such as TNF-a, IL-6, and IL-8, which can further enhance the inflammatory response (81-83).
Reulation ofICAM-1 Expression
Distinct cis-regulatory elements within the ICAM-1 promoter that respond to oxidants, as well as TNF-a, have been functionally identified using endothelial cells (84) . Recent As there appears to be some component of transcriptional regulation to IL-6 expression, we have begun to examine the ability of nuclear proteins to bind to sites present in the IL-6 promoter using EMSAs. Nuclear extracts from cells exposed to PXO or TNF-a were used in shift assays with either the NF-iKB or NFIL-6 site found in the IL-6 promoter. Interestingly, extracts treated with PXO or TNF-a had different patterns of binding to these sequences. TNF-ac-treated extracts exhibited a greater amount of binding to the NF-iKB site when compared with binding of proteins from control extracts. However, no changes in the ability of the treated extracts to bind the NFIL-6 site were observed. In contrast, nuclear extracts from PXO-treated cells caused an increase in binding to the NFIL-6 site but not the NF-cB site (86). These data suggest different modes of transcriptional regulation of IL-6 gene expression in response to PXO or TNF-a. In addition, they suggest that although has not been traditionally considered an oxidant-sensitive transcription factor, it does appear to respond to exogenous oxidant stress. It now remains to determine whether these transcription factor sites play a role in differential expression of IL-6 in response to these two stimuli in vivo.
Conclusions
ROS/RNS can play a variety of roles in signaling pathways that lead to changes in expression of proteins important to the development of inflammatory airway and lung disease. ROS/RNS can serve as direct injury-causing agents, as exogenous stimuli that cause production of inflammatory mediators from epithelial cells, as intracellular signaling molecules, and as modulators of the redox state in epithelial cells. In these capacities, ROS/RNS appear to function as modulators of the expression of epithelial genes whose products are proinflammatory or act in other ways to prolong the presence of inflammatory cells in diseased airways. Intracellular ROS/RNS can serve as signaling molecules in signal transduction cascades that ultimately trigger changes in expression of epithelial genes. As the redox state within epithelial cells changes during the production of such reactive species, transcription factors become activated. In this manner, the transcriptionally controlled expression of gene products such as IL-6, ICAM-1, and mucin is modulated during inflammatory airway disease or inhaled environmental insult. Whether an effective defensive mechanism or a pathologic state results in the airway likely depends on the precise regulation of the expression of such genes via mechanisms involving ROS/RNS.
